5-Aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells

37Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Background - Reactive oxygen and nitrogen derived species produced by activated neutrophils have been implicated in the damage of mucosal proteins including the inhibition of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the active inflammatory lesion in patients with inflammatory bowel disease (IBD). This study investigated the efficacy of currently used IBD therapeutics to prevent injury mediated by reactive oxygen and nitrogen derived species. Methods - GAPDH activity of human colon epithelial cells was used as a sensitive indicator of injury produced by reactive oxygen and nitrogen derived species. HCT116 cells (106/ml phosphate buffered saline; 37°C) were incubated in the presence of 5-aminosalicylic acid (5-ASA), 6- mercaptopurine, methylprednisolone, or metronidazole before exposure to H2O2, HOCl, or NO in vitro. HCT116 cell GAPDH enzyme activity was determined by standard procedures. Cell free reactions between 5-ASA and HOCl were analyzed by spectrophotometry and fluorimetry to characterize the mechanism of oxidant scavenging. Results - GAPDH activity of HCT116 cells was inhibited by the oxidants tested: the concentration that produced 50% inhibition (IC50) was 44.5 (2.1) μM for HOCl, 379.8 (21.3) μM for H2O2, and 685.8 (103.8) μM for NO (means (SEM)). 5-ASA was the only therapeutic compound tested to show efficacy (p<0.05) against HOCl mediated inhibition of enzyme activity; however, it was ineffective against H2O2 and NO mediated inhibition of GAPDH. Methylprednisolone, metronidazole, and the thiol- containing 6-mercaptopurine were ineffective against all oxidants. Studies at ratios of HOCl:5-ASA achievable in the mucosa showed direct scavenging to be the mechanism of protection of GAPDH activity. Mixing 5-ASA and HOCl before addition to the cells resulted in significantly greater protection of GAPDH activity than when HOCl was added to cells preincubated with 5-ASA. The addition of 5-ASA after HOCl exposure did not restore GAPDH activity. Conclusions - Therapies based on 5-ASA may play a direct role in scavenging the potent neutrophil oxidant HOCl, thereby protecting mucosal GAPDH from oxidative inhibition. These findings suggest that strategies for the further development of new HOCl scavenging compounds may be useful in the treatment of IBD.

References Powered by Scopus

Cytokines in intestinal inflammation: Pathophysiological and clinical considerations

601Citations
N/AReaders
Get full text

Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease

325Citations
N/AReaders
Get full text

Oxygen radicals in ulcerative colitis

281Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation

1124Citations
N/AReaders
Get full text

Intestinal inflammation and cancer

941Citations
N/AReaders
Get full text

Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease

363Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

McKenzie, S. M., Doe, W. F., & Buffinton, G. D. (1999). 5-Aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells. Gut, 44(2), 180–185. https://doi.org/10.1136/gut.44.2.180

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

64%

Researcher 3

21%

Professor / Associate Prof. 2

14%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 6

50%

Medicine and Dentistry 4

33%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Chemistry 1

8%

Save time finding and organizing research with Mendeley

Sign up for free